Australian researchers have isolated five strains of beneficial gut bacteria that may lead to the development of new treatments for inflammatory bowel disease (IBD) and reduce the risk of certain types of bowel cancer.
IBD is thought to be caused by an abnormal composition of gut bacteria which creates an immune response in genetically susceptible people, thus resulting in relapsing gut inflammation and debilitating symptoms.
